Effect of low concentration of diacylglycerol on mildly postprandial hypertriglyceridemia.

OBJECTIVE: Previous studies have demonstrated that a high concentration of diacylglycerol (DAG) oil (approximately 80% in 10 g of test oil) suppressed increases in postprandial serum triglyceride (TG), particularly hypertriglyceridemia. However, the effects of a lower concentration of DAG oil have not been demonstrated. In the present study, the effective dose of DAG oil was determined in hypertriglyceridemia. METHODS: Randomized, double-blind, cross-over design study was conducted using 22 patients with mild hypertriglyceridemia. Changes in postprandial serum lipid concentrations were analyzed after ingestion of 10 g of test oil containing 1.3% (control), 27.3% (low dose), 54.6% (medium dose) or 80.8% (high dose) of emulsified DAG. RESULTS: The expanded Williams test indicated that the DAG dose that was most effective at altering postprandial serum TG and chylomicron-TG concentrations was ≥ 27.3% DAG in 10 g of test oil; ≥ 54.6% DAG in 10 g of test oil was needed to have an impact on postprandial serum apolipoprotein B-48 concentrations. Additionally, DAG was more effective in subjects with both hypertriglyceridemia and hypertension. In the current study, systolic blood pressure correlated with the increase in postprandial serum TG, suggesting that DAG improves hypertriglyceridemia, particularly when it is accompanied by hypertension. CONCLUSION: DAG oil could be useful as an initial dietetic therapy for the treatment of postprandial hypertriglyceridemia with hypertension. The effective dose was ≥ 27.3% DAG in 10 g of oil.

Shoyu polysaccharides from soy sauce improve quality of life for patients with seasonal allergic rhinitis: a double-blind placebo-controlled clinical study.

Soy sauce (Shoyu) is a traditional fermented seasoning of East Asian countries and is available throughout the world. We obtained polysaccharides from raw soy sauce, and showed the anti-allergic activities of these Shoyu polysaccharides (SPS) in vitro and in vivo. The present study determined whether oral supplementation of SPS is an effective intervention for patients with seasonal allergic rhinitis. In an 8-week randomized, double-blind, placebo-controlled parallel group study, patients with mild seasonal allergic rhinitis were treated with 600 mg of SPS (n=25) or placebo (n=26) each day. After 4 weeks of treatment with SPS, symptom scores such as sneezing, nasal stuffiness, and hindrance of daily life were significantly different (P<0.05) from those in placebo-treated groups. The total symptom score, calculated from the sum of individual scores, showed a significant difference (P<0.05) between the 2 groups after 4-8 weeks. On nasal examination by the investigator, the color of the inferior turbinate in SPS-treated patients was significantly different (P<0.05) from that in placebo-treated patients between weeks 4 and 8, and the nasal symptom scores for color of inferior turbinate, watery discharge, and state of sniffles were also significantly different (P<0.05) from those in the placebo-treated group after 8 weeks. In conclusion, SPS of soy sauce improved the quality of life of patients with seasonal allergic rhinitis, and soy sauce would be useful in an anti-allergic therapy utilizing daily foods.

Quality of life improvement with soy sauce ingredients, Shoyu polysaccharides, in perennial allergic rhinitis: a double-blind placebo-controlled clinical study.

Soy sauce (Shoyu) is a traditional fermented seasoning of East Asian countries and available throughout the world. We obtained polysaccharides from raw soy sauce, and showed the anti-allergic activities of these Shoyu polysaccharides (SPS) in vitro and in vivo. The present study determined whether oral supplementation of SPS is an effective intervention for patients with perennial allergic rhinitis. In a 4-week randomized, double-blind, placebo-controlled parallel group study, patients with mild perennial allergic rhinitis were treated with 600 mg of SPS (n=11) or placebo (n=10) each day. After 4 weeks of treatment with SPS, a reduction in symptom scores for runny nose, sore throat, and itchy eyes were significantly changed from the baseline within the group (p<0.05), but no change in these scores was observed over 4 weeks of treatment in the placebo group. However, differences in the symptom scores during the study period were not significantly different between the groups. The total symptom score, calculated from the sum of individual scores, showed a significant difference between the 2 groups after 4 weeks of treatment (p<0.05). The efficacy of global symptoms score, which was defined as the adjusted mean change from baseline during 4 weeks of treatment, also showed a significant improvement in the SPS group (p<0.05). An overall evaluation of the medication's effectiveness after 4 weeks treatment showed significant differences between the SPS- and placebo-treated groups (p<0.05). In conclusion, SPS of soy sauce improved the quality of life for patients with perennial allergic rhinitis, and soy sauce would be useful in an anti-allergic therapy utilizing everyday foods.